SEC Filing Summary: Officer and Director Stock Transaction

Jonathan Adam Feldschuh, Chief Scientific Officer and Director of DAXOR CORP, was granted 25,000 shares of Daxor Common Stock on June 23, 2026. These shares are set to vest on June 23, 2026. Following this transaction, Mr. Feldschuh owns 78,908 shares of common stock. The transaction code is 'A', indicating an acquisition, with a transaction price of $0.00 per share, as noted in footnote F1. The filing is Form 4, signed on June 25, 2026.